CDKN2A and hepatocellular carcinoma: Among the best-described pathways driving HCC, there are Wnt/β-catenin, MAPK, p14ARF/p53, p16INK4A/Rb, transforming growth factor-β (TGF-β) and PTEN/Akt [11].